Eribulin

Eribulin is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin is primarily used in the treatment of metastatic breast cancer. It may also be used for other types of cancer, depending on medical guidelines. The medication is administered intravenously and targets cancer cells to inhibit their growth.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary among individuals and should be discussed with a healthcare provider.

Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper safety protocols when administering the medication. Patients should be monitored for any adverse reactions and report them to their healthcare provider immediately.

Eribulin may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin.